Neurol. praxi. 2022;23(1):54-56 | DOI: 10.36290/neu.2021.050
Nowadays, in times of new possibilities of molecular genetic testing, muscle biopsy is no longer the diagnostic method of choice in most myopathies. In hereditary myopathies, a biopsy is indicated only if the findings from molecular biological analysis is non-conclusive or does not correlate with the clinical phenotype of the disease. On the contrary, muscle biopsy is indicated in all cases of autoimmune processes - myositis, immune-mediated necrotizing myopathies, or vasculitis.
Received: July 23, 2021; Revised: July 23, 2021; Accepted: July 28, 2021; Prepublished online: July 28, 2021; Published: March 14, 2022 Show citation
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...
Go to original source...
Go to PubMed...